Sana Biotechnology, Inc. (SANA)
3.91
+0.04
(+1.03%)
USD |
NASDAQ |
Sep 01, 12:01
Sana Biotechnology Cash from Operations (TTM) : -132.24M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -132.24M |
| March 31, 2026 | -132.55M |
| December 31, 2025 | -143.83M |
| September 30, 2025 | -158.35M |
| June 30, 2025 | -180.74M |
| March 31, 2025 | -206.18M |
| December 31, 2024 | -223.15M |
| September 30, 2024 | -227.95M |
| June 30, 2024 | -239.68M |
| March 31, 2024 | -239.94M |
| Date | Value |
|---|---|
| December 31, 2023 | -253.58M |
| September 30, 2023 | -277.69M |
| June 30, 2023 | -278.94M |
| March 31, 2023 | -291.61M |
| December 31, 2022 | -290.05M |
| September 30, 2022 | -324.08M |
| June 30, 2022 | -309.77M |
| March 31, 2022 | -278.85M |
| December 31, 2021 | -251.05M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Twist Bioscience Corp. | -53.07M |
| Beam Therapeutics, Inc. | -359.38M |
| Prime Medicine, Inc. | -156.05M |
| Intellia Therapeutics, Inc. | -346.64M |
| Moderna, Inc. | -1.073B |